DRGEM Corporation - Asset Resilience Ratio

Latest as of March 2026: 1.34%

DRGEM Corporation (263690) has an Asset Resilience Ratio of 1.34% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₩1.72 Billion
≈ $1.17 Million USD Cash + Short-term Investments

Total Assets

₩128.48 Billion
≈ $87.07 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how DRGEM Corporation's Asset Resilience Ratio has changed over time. Check DRGEM Corporation PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down DRGEM Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is DRGEM Corporation worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩1.72 Billion 1.34%
Total Liquid Assets ₩1.72 Billion 1.34%

Asset Resilience Insights

  • Limited Liquidity: DRGEM Corporation maintains only 1.34% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

DRGEM Corporation Industry Peers by Asset Resilience Ratio

Compare DRGEM Corporation's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Novocure Ltd
NASDAQ:NVCR
Medical Devices 43.72%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
Medical Devices 10.88%
Bactiguard Holding AB (publ)
ST:BACTI-B
Medical Devices 8.12%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%

Annual Asset Resilience Ratio for DRGEM Corporation (2015–2025)

The table below shows the annual Asset Resilience Ratio data for DRGEM Corporation.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 2.00% ₩2.43 Billion
≈ $1.65 Million
₩121.97 Billion
≈ $82.65 Million
-11.76pp
2024-12-31 13.76% ₩16.78 Billion
≈ $11.37 Million
₩122.00 Billion
≈ $82.68 Million
-0.98pp
2023-12-31 14.73% ₩18.92 Billion
≈ $12.82 Million
₩128.41 Billion
≈ $87.02 Million
-8.47pp
2022-12-31 23.20% ₩29.39 Billion
≈ $19.92 Million
₩126.71 Billion
≈ $85.87 Million
-3.16pp
2021-12-31 26.36% ₩22.16 Billion
≈ $15.01 Million
₩84.05 Billion
≈ $56.96 Million
+0.10pp
2020-12-31 26.26% ₩19.07 Billion
≈ $12.92 Million
₩72.63 Billion
≈ $49.22 Million
+8.21pp
2019-12-31 18.04% ₩11.38 Billion
≈ $7.71 Million
₩63.05 Billion
≈ $42.73 Million
-2.62pp
2018-12-31 20.66% ₩9.56 Billion
≈ $6.48 Million
₩46.29 Billion
≈ $31.37 Million
+8.77pp
2017-12-31 11.89% ₩4.09 Billion
≈ $2.77 Million
₩34.41 Billion
≈ $23.32 Million
+1.16pp
2016-12-31 10.73% ₩2.99 Billion
≈ $2.02 Million
₩27.82 Billion
≈ $18.85 Million
+10.73pp
2015-12-31 0.00% ₩11.00K
≈ $7.45
₩23.54 Billion
≈ $15.95 Million
--
pp = percentage points

About DRGEM Corporation

KQ:263690 Korea Medical Devices
Market Cap
$37.07 Million
₩54.70 Billion KRW
Market Cap Rank
#22964 Global
#1481 in Korea
Share Price
₩5020.00
Change (1 day)
+2.03%
52-Week Range
₩4750.00 - ₩6510.00
All Time High
₩21390.25
About

DRGEM Corporation manufactures and sells diagnostic radiography systems. It offers high frequency X-ray generators; conventional and digital radiography systems; and ACQUIDR, a digital imaging system. DRGEM Corporation exports its products. The company was founded in 2003 and is headquartered in Gwangmyeong-si, South Korea.